Cannabidiol has many actions, including anti-inflammatory, neuroprotectant and antioxidant properties. Neurodegenerative disease is caused by a slow progression of neuronal function in specific areas of the brain which is recognized by cognitive, motor, and/or behavioral dysfunctions.
This attributes to one of the main causes of death in industrialized countries.
CNS Neuroscience and Therapeutics has reviewed CBD for its prevention and management of main neurodegenerative disorders by protecting neuronal and nonneuronal cells against factors that effect these functions. This includes ß-amyloid (plaque found in the brain of AD patients) or 6-hydroxydopamine (a neurotoxic compound that destroys neurotransmitters like dopamine) and glutamate.
Important clinical trials have confirmed the potential pharmacological activity of CBD in the management of clinical symptoms and the slow-down of the progression of a variety of pathologies.
• Alzheimer’s Disease
• Multiple Sclerosis
• Parkinson’s Disease
• Amyotrophic Lateral Sclerosis (ALS)